$1.12 Billion is the total value of Broadfin Capital, LLC's 72 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 25.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON PHARMA PLC | $99,773,000 | -11.7% | 5,503,182 | -19.8% | 8.94% | -18.6% |
| RTRX | Buy | RETROPHIN INC | $77,642,000 | +63.7% | 3,469,271 | +30.3% | 6.96% | +50.9% |
| NVDQ | Sell | NOVADAQ TECHNOLOGIES INC | $59,866,000 | +11.3% | 5,174,209 | -5.3% | 5.36% | +2.6% |
| PGNX | PROGENICS PHARMACEUTICALS IN | $56,661,000 | +50.0% | 8,951,169 | 0.0% | 5.08% | +38.3% | |
| FLML | FLAMEL TECHNOLOGIES SAsponsored adr | $54,491,000 | +15.5% | 4,394,464 | 0.0% | 4.88% | +6.4% | |
| ANGO | Sell | ANGIODYNAMICS INC | $50,703,000 | -2.2% | 2,890,679 | -19.9% | 4.54% | -9.8% |
| HRTX | Buy | HERON THERAPEUTICS INC | $49,105,000 | +117.6% | 2,850,000 | +128.0% | 4.40% | +100.6% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $34,425,000 | +67.9% | 1,447,053 | +12.9% | 3.08% | +54.8% |
| XBI | New | SPDR SERIES TRUSTput | $33,145,000 | – | 500,000 | +100.0% | 2.97% | – |
| ENDP | Buy | ENDO INTL PLC | $29,309,000 | +82.7% | 1,454,538 | +41.4% | 2.63% | +68.5% |
| PETX | Sell | ARATANA THERAPEUTICS INC | $28,885,000 | +33.3% | 3,085,979 | -10.0% | 2.59% | +22.9% |
| ATRS | ANTARES PHARMA INC | $25,007,000 | +60.0% | 14,885,393 | 0.0% | 2.24% | +47.4% | |
| LBIO | Sell | LION BIOTECHNOLOGIES INC | $21,713,000 | -15.5% | 2,638,259 | -16.8% | 1.95% | -22.1% |
| REPH | Buy | RECRO PHARMA INC | $21,659,000 | +32.2% | 2,450,086 | +18.9% | 1.94% | +21.9% |
| ARLZ | Buy | ARALEZ PHARMACEUTICALS INC | $21,374,000 | +57.7% | 4,406,990 | +7.3% | 1.92% | +45.4% |
| HZNP | Buy | HORIZON PHARMA PLCcall | $19,037,000 | +131.2% | 1,050,000 | +110.0% | 1.71% | +113.0% |
| OPHT | Buy | OPHTHOTECH CORP | $18,913,000 | +108.9% | 410,000 | +131.1% | 1.70% | +92.6% |
| MDGN | MEDGENICS INC | $18,773,000 | +0.4% | 3,370,306 | 0.0% | 1.68% | -7.5% | |
| TLGT | Sell | TELIGENT INC NEW | $16,734,000 | -6.9% | 2,201,901 | -12.5% | 1.50% | -14.1% |
| ADXS | Sell | ADVAXIS INC | $16,726,000 | +22.3% | 1,564,679 | -7.4% | 1.50% | +12.7% |
| RXDX | IGNYTA INC | $14,194,000 | +16.1% | 2,256,546 | 0.0% | 1.27% | +7.0% | |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $14,139,000 | +77.0% | 1,347,810 | +146.0% | 1.27% | +63.1% |
| BDSI | BIODELIVERY SCIENCES INTL IN | $14,010,000 | +14.4% | 5,188,794 | 0.0% | 1.26% | +5.5% | |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDadr | $13,803,000 | – | 300,000 | +100.0% | 1.24% | – |
| AEGR | Buy | AEGERION PHARMACEUTICALS INC | $12,953,000 | +116.8% | 4,361,291 | +8.8% | 1.16% | +99.8% |
| ACOR | New | ACORDA THERAPEUTICS INC | $12,626,000 | – | 604,700 | +100.0% | 1.13% | – |
| DSCI | DERMA SCIENCES INC | $11,965,000 | +18.5% | 2,562,104 | 0.0% | 1.07% | +9.3% | |
| SPNE | SEASPINE HLDGS CORP | $11,121,000 | -3.5% | 1,100,007 | 0.0% | 1.00% | -11.1% | |
| QLTI | Buy | QLT INC | $10,856,000 | +72.0% | 5,269,831 | +18.5% | 0.97% | +58.5% |
| CORI | CORIUM INTERNATIONAL ORD | $10,808,000 | +62.3% | 1,919,721 | 0.0% | 0.97% | +49.5% | |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $10,715,000 | +6.1% | 3,359,049 | -28.2% | 0.96% | -2.2% |
| ELGX | Sell | ENDOLOGIX INC | $10,240,000 | -17.8% | 800,000 | -20.0% | 0.92% | -24.2% |
| PRTK | Sell | PARATEK PHARMACEUTICALS INC | $10,228,000 | -8.5% | 786,134 | -2.1% | 0.92% | -15.6% |
| XENT | Sell | INTERSECT ENT INC | $10,115,000 | +10.1% | 638,600 | -10.1% | 0.91% | +1.6% |
| ZGNX | ZOGENIX INC | $10,085,000 | +42.0% | 882,312 | 0.0% | 0.90% | +30.8% | |
| RDHL | Sell | REDHILL BIOPHARMA LTDsponsored ads | $9,962,000 | +24.4% | 717,203 | -2.7% | 0.89% | +14.6% |
| MDCO | MEDICINES CO | $9,646,000 | +12.2% | 255,600 | 0.0% | 0.86% | +3.3% | |
| DEPO | Buy | DEPOMED INC | $9,475,000 | +48.7% | 379,474 | +16.9% | 0.85% | +37.2% |
| CPRX | CATALYST PHARMACEUTICALS INC | $8,938,000 | +53.5% | 8,200,000 | 0.0% | 0.80% | +41.5% | |
| DRRX | Buy | DURECT CORP | $8,889,000 | +151.2% | 6,395,206 | +120.5% | 0.80% | +131.7% |
| New | EGALET CORPnote 5.500% 4/0 | $8,781,000 | – | 10,000,000 | +100.0% | 0.79% | – | |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $8,648,000 | +31.1% | 1,656,706 | 0.0% | 0.78% | +20.9% | |
| EGLTQ | EGALET CORP | $8,635,000 | +53.4% | 1,134,750 | 0.0% | 0.77% | +41.5% | |
| ADMA | ADMA BIOLOGICS INC | $8,060,000 | +21.7% | 1,113,293 | 0.0% | 0.72% | +12.1% | |
| AVIR | AVIRAGEN THERAPEUTICS INC | $6,694,000 | +37.1% | 3,486,711 | 0.0% | 0.60% | +26.3% | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $6,610,000 | +74.5% | 1,000,000 | +44.1% | 0.59% | +60.9% |
| IDRA | Sell | IDERA PHARMACEUTICALS INC | $6,215,000 | +31.3% | 2,427,745 | -21.6% | 0.56% | +21.1% |
| RPTP | Sell | RAPTOR PHARMACEUTICAL CORP | $5,963,000 | -82.8% | 664,800 | -89.7% | 0.53% | -84.1% |
| SCYX | SCYNEXIS INC | $5,717,000 | +78.3% | 1,477,273 | 0.0% | 0.51% | +64.1% | |
| CSII | Sell | CARDIOVASCULAR SYS INC DEL | $5,473,000 | -75.7% | 230,532 | -81.2% | 0.49% | -77.7% |
| NVRO | Sell | NEVRO CORP | $5,277,000 | -81.8% | 50,555 | -87.1% | 0.47% | -83.2% |
| HRTX | New | HERON THERAPEUTICS INCcall | $5,169,000 | – | 300,000 | +100.0% | 0.46% | – |
| PCRX | Buy | PACIRA PHARMACEUTICALS INC | $5,156,000 | +63.7% | 150,680 | +61.4% | 0.46% | +51.0% |
| PCRX | New | PACIRA PHARMACEUTICALS INCcall | $5,133,000 | – | 150,000 | +100.0% | 0.46% | – |
| ADHD | Buy | ALCOBRA LTD | $5,057,000 | -27.7% | 2,047,449 | +31.5% | 0.45% | -33.4% |
| TENX | TENAX THERAPEUTICS INC | $4,557,000 | -9.6% | 1,968,631 | 0.0% | 0.41% | -16.7% | |
| New | PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $4,340,000 | – | 15,500,000 | +100.0% | 0.39% | – | |
| NVET | Buy | NEXVET BIOPHARMA PUB LTD CO | $4,222,000 | -9.0% | 1,017,255 | +1.7% | 0.38% | -16.2% |
| MDWD | MEDIWOUND LTD | $4,089,000 | -2.4% | 530,985 | 0.0% | 0.37% | -10.1% | |
| ANTH | ANTHERA PHARMACEUTICALS INC | $3,637,000 | +1.9% | 1,154,674 | 0.0% | 0.33% | -6.1% | |
| CFRX | Buy | CONTRAFECT CORP | $3,544,000 | +87.9% | 1,429,109 | +119.0% | 0.32% | +73.8% |
| TRVN | TREVENA INC | $3,321,000 | +7.1% | 492,000 | 0.0% | 0.30% | -1.0% | |
| TRUP | New | TRUPANION INC | $2,680,000 | – | 158,600 | +100.0% | 0.24% | – |
| TNDM | New | TANDEM DIABETES CARE INC | $2,561,000 | – | 334,300 | +100.0% | 0.23% | – |
| WINT | WINDTREE THERAPEUTICS INC | $1,991,000 | +32.6% | 777,797 | 0.0% | 0.18% | +21.9% | |
| CDTX | CIDARA THERAPEUTICS INC | $1,911,000 | +11.1% | 166,875 | 0.0% | 0.17% | +2.4% | |
| DXTRQ | Sell | DEXTERA SURGICAL INC | $1,587,000 | +2.3% | 844,167 | -2.1% | 0.14% | -6.0% |
| CASM | Sell | CAS MED SYS INC | $972,000 | -34.9% | 562,030 | -30.7% | 0.09% | -40.0% |
| RXII | Sell | RXI PHARMACEUTICALS CORP NEW | $585,000 | -50.1% | 316,010 | -35.3% | 0.05% | -54.4% |
| SSKN | STRATA SKIN SCIENCES INC | $510,000 | -13.0% | 961,422 | 0.0% | 0.05% | -19.3% | |
| DPRX | Exit | DIPEXIUM PHARMACEUTICALS INC | $0 | – | -44,774 | -100.0% | -0.04% | – |
| TNXP | Exit | TONIX PHARMACEUTICALS HLDG C | $0 | – | -433,911 | -100.0% | -0.08% | – |
| RTTR | Exit | RITTER PHARMACEUTICALS INC | $0 | – | -768,418 | -100.0% | -0.11% | – |
| PLX | Exit | PROTALIX BIOTHERAPEUTICS INC | $0 | – | -2,025,268 | -100.0% | -0.13% | – |
| ENDP | Exit | ENDO INTL PLCcall | $0 | – | -200,000 | -100.0% | -0.30% | – |
| Exit | PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $0 | – | -15,500,000 | -100.0% | -0.35% | – | |
| GHDX | Exit | GENOMIC HEALTH INC | $0 | – | -270,400 | -100.0% | -0.68% | – |
| Exit | EGALET CORPnote 5.500 4/0 | $0 | – | -10,000,000 | -100.0% | -0.74% | – | |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -550,000 | -100.0% | -11.20% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIODELIVERY SCIENCES INTL IN | 27 | Q4 2019 | 4.8% |
| HERON THERAPEUTICS INC | 24 | Q4 2019 | 9.0% |
| LA JOLLA PHARMACEUTICAL CO | 24 | Q4 2019 | 7.7% |
| RECRO PHARMA INC | 24 | Q4 2019 | 4.1% |
| ANTARES PHARMA INC | 24 | Q3 2019 | 3.4% |
| RETROPHIN INC | 23 | Q3 2019 | 7.0% |
| ARATANA THERAPEUTICS INC | 22 | Q2 2019 | 8.1% |
| MIRATI THERAPEUTICS INC | 22 | Q1 2019 | 7.9% |
| CATALYST PHARM PARTNERS INC | 22 | Q3 2019 | 6.2% |
| ANGIODYNAMICS INC | 21 | Q3 2018 | 6.6% |
View Broadfin Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eiger BioPharmaceuticals, Inc.Sold out | January 04, 2021 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL COSold out | January 04, 2021 | 0 | 0.0% |
| STRATA Skin Sciences, Inc. | June 23, 2020 | 1,529,392 | 4.5% |
| Teligent, Inc.Sold out | February 25, 2020 | 0 | 0.0% |
| Neos Therapeutics, Inc.Sold out | February 14, 2020 | 0 | 0.0% |
| Aclaris Therapeutics, Inc. | February 13, 2020 | 1,888,039 | 4.6% |
| Adamas Pharmaceuticals IncSold out | February 13, 2020 | 0 | 0.0% |
| ADMA BIOLOGICS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
| AVADEL PHARMACEUTICALS PLC | February 13, 2020 | 1,029,012 | 2.8% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
View Broadfin Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2022-03-22 |
| 4 | 2022-02-15 |
| 4 | 2022-01-31 |
| 4 | 2021-11-22 |
| 4 | 2021-11-15 |
| 4 | 2021-11-09 |
| 4 | 2021-08-10 |
| 4 | 2021-05-13 |
| SC 13G/A | 2021-01-04 |
| SC 13G/A | 2021-01-04 |
View Broadfin Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.